The U.S. Court of Appeals for the Fifth Circuit on Monday temporarily blocked a ruling that overturned the Affordable Care Act's provision requiring health plans to cover preventive care while the court reviews the case, in today's bite-sized hospital and health industry news from Illinois, Louisiana, and Rhode Island.

• Illinois: The Illinois Department of Healthcare & Family Services and the Illinois Department of Human Services announced on Friday that the state's Application for Benefits Eligibility's "Manage My Case" portal had been breached. "Suspicious accounts" were made and linked to existing user accounts. The departments said they discovered the suspicious accounts on March 13. The new accounts were able to link to existing accounts by providing customers' birth dates and Social Security numbers and by correctly answering security questions. The departments said it's unclear how many people have been affected by the breach. (Davis, Crain's Chicago Business/Modern Healthcare, 5/12)
• Louisiana: The U.S. Court of Appeals for the Fifth Circuit on Monday temporarily blocked a  ruling  that overturned the Affordable Care Act's (ACA) provision requiring health plans to cover preventive care recommended by the U.S. Preventive Services Task Force (USPSTF), including cancer and chronic disease screenings and pregnancy care, while the court reviews the case. In April, Judge Reed O'Connor of the U.S District Court for the Northern District of Texas ruled the ACA provision was unconstitutional and that the USPSTF violates the U.S. Constitution's appointments clause, since its members weren't appointed by the president and approved by the Senate. (Baumgaertner, New York Times, 5/15; González, Axios, 5/15)
• Rhode Island: CVS Health on Monday announced it will shut down its clinical trials division, as the division no longer aligns with CVS' long-term strategy. The division, first launched in 2021, will shut down at the end of 2024. So far, the division has worked with more than 30 drugmakers on 50 phase I, II, and IV studies that involved 33,000 participants. "We'll work with our trial sponsors to ensure a smooth transition, as well as continuity of care and minimal disruptions for patients," a spokesperson said. "We're working to support impacted colleagues, and will provide career transition support for those unable to find another role within CVS Health." (Hartnett, Modern Healthcare, 5/15)